1. The Potential Immune-Eliciting Cancer Testis Antigens in Colorectal Cancer
   Joanne Ern Chi Soh et al, 2018, Immunotherapy CrossRef
2. Challenges and exploration for immunotherapies targeting cold colorectal cancer
   Dan-Dan Li et al, 2023, World Journal of Gastrointestinal Oncology CrossRef
3. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
   Yoko Oshima et al, 2016, Journal of Gastroenterology CrossRef
4. Optimization of norovirus virus‐like particle production in Pichia pastoris using a real‐time near‐infrared bioprocess monitor
   Stephanie A. Parker et al, 2016, Biotechnology Progress CrossRef
5. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
   Remy Thomas et al, 2018, Frontiers in Immunology CrossRef
6. Nature of tumour rejection antigens in ovarian cancer
   Muzamil Y. Want et al, 2018, Immunology CrossRef
7. Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
   Nassiba Taib et al, 2023, Journal of Translational Medicine CrossRef
8. Case-Control Study: Smoking History Affects the Production of Tumor Antigen–Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease–Free Group
   Dagmar Myšíková et al, 2017, Journal of Thoracic Oncology CrossRef
9. Expression and immunogenicity of NY-ESO-1 in colorectal cancer
   Ya Li et al, 2017, Experimental and Therapeutic Medicine CrossRef
10. Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
    Afsheen Raza et al, 2020, Journal of Translational Medicine CrossRef